In early February, AGA released the following statement on the U.S. travel ban:
Science and illness ignore borders and political divides. That is why AGA is concerned that the recent U.S. executive order on immigration could limit scientific exchange, delay patient care, and impair medical training.
AGA is committed to diversity, which includes race, ethnicity, and national origin. Diversity within training programs and laboratories in the United States built today’s practice of gastroenterology. Scientists from around the world publish in our journals, work in our laboratories, train in our programs, and present data at Digestive Disease Week.® This exchange leads to better patient care, and very sick patients travel to the U.S. from around the world for the best digestive health care.
In light of these concerns, AGA adds our support to a growing number of medical institutions urging the administration to consider the devastating impact of the executive order on the health of the nation that will result from turning away patients, health professionals, and researchers. The recent immigration policy is clearly detrimental to America’s leadership role in advancing health care and to the standing of the U.S. within the international community.
“Know that the policies of AGA’s home country in no way reflect our position as an organization, and we continue to welcome and support physicians and investigators from all nations,” said AGA Institute President Timothy Wang, MD, AGAF. “We understand the impact that the recent ban has had on many, and apologize for any hurt or disruption it may have caused in your lives or careers.”
To better advocate on behalf of international members and patients, Dr. Wang invites members to the AGA Community, either publicly or anonymously, to share your stories about how a travel ban could affect your patients, practice, academic center, training program, or lab.
For more updates, please visit gastro.org.
